Immuta provides a unified authorization layer for data access, intended for large enterprises that handle data across multiple systems. It emphasizes fast, rule-based decisions applied to both humans and AI agents, aiming to let people access data quickly while maintaining governance and trust.
Immuta operates as a policy engine that enforces rules inside the data infrastructure, compiling policies into real controls within data systems. It supports a model where a single policy can govern access across diverse data platforms, and where decisions are recorded to support auditing and compliance.
The platform presents agentic data access, including just-in-time permissions, and notes that access decisions happen in real time as part of the data work stream. It emphasizes fast responses, with decisions made at the moment of the request, and accountability through auditable decision trails.
It highlights that agents can request data at question time, and that access is granted at the source with careful scoping and time limits to minimize exposure.
Manus is a versatile AI agent designed to transform thoughts into actions, streamlining tasks in both professional and personal settings. Its primary value lies in its ability to manage various responsibilities efficiently, allowing users to relax while it handles their to-do lists. With Manus, users can experience increased productivity and peace of mind, knowing that their tasks are being completed seamlessly.
Airtable Assistant brings AI into Airtable workflows with Omni and Field Agents for building apps and automations.
Prolific helps researchers and AI developers collect high-quality human data from verified participants, with API access and managed services.
Superhuman is an AI productivity suite with Mail, Docs, and Go that work across apps and tabs for teams and professionals.
SYNTX.AI is a unified platform offering 100+ AI models in a single dashboard for web and Telegram, with enterprise options for teams.
AI-powered symptom checker developed by doctors for health guidance.